60 Degrees Pharmaceuticals, Inc. (SXTP)
0.9193
-0.01
(-1.16%)
USD |
NASDAQ |
Sep 04, 16:00
0.9312
+0.01
(+1.29%)
After-Hours: 20:00
60 Degrees Pharmaceuticals SG&A Expense (TTM) : 6.600M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.600M |
| March 31, 2026 | 6.483M |
| December 31, 2025 | 6.280M |
| September 30, 2025 | 6.411M |
| June 30, 2025 | 6.119M |
| March 31, 2025 | 5.636M |
| December 31, 2024 | 5.025M |
| September 30, 2024 | 5.110M |
| June 30, 2024 | 5.209M |
| Date | Value |
|---|---|
| March 31, 2024 | 4.542M |
| December 31, 2023 | 4.242M |
| September 30, 2023 | 2.965M |
| June 30, 2023 | 1.826M |
| March 31, 2023 | 1.626M |
| September 30, 2022 | 0.8515M |
| March 31, 2022 | 0.4379M |
| December 31, 2021 | 0.2632M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Harrow, Inc. | 175.69M |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Corcept Therapeutics, Inc. | 556.47M |
| Veru, Inc. | 16.05M |
| Johnson & Johnson | 25.14B |